T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$3.76B |
| 2 |
Cigna
CI
|
+$1.44B |
| 3 |
Bristol-Myers Squibb
BMY
|
+$1.26B |
| 4 |
Occidental Petroleum
OXY
|
+$763M |
| 5 |
Danaher
DHR
|
+$762M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
PCYC
PHARMACYCLICS INC
PCYC
|
+$2.46B |
| 2 |
Wynn Resorts
WYNN
|
+$1.11B |
| 3 |
Netflix
NFLX
|
+$1.03B |
| 4 |
PCP
PRECISION CASTPARTS CORP
PCP
|
+$975M |
| 5 |
TWTR
Twitter, Inc.
TWTR
|
+$909M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 22.87% |
| 2 | Financials | 13.64% |
| 3 | Consumer Discretionary | 13.54% |
| 4 | Industrials | 10.67% |
| 5 | Technology | 10.39% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1026
Valley National Bancorp
VLY
$8.25B
| $28.3M | 0.01% |
2,747,379
-4,098
| -0.1% | -$39.9K |
|
1027
FRP Holdings
FRPH
$425M
| $28.3M | 0.01% |
1,746,660
+600
| +0% | +$9.86K |
|
1028
Main Street Capital
MAIN
$5.47B
| $28.2M | 0.01% |
883,180
+19,700
| +2% | +$615K |
|
1029
TETRA Technologies
TTI
$1.29B
| $28.2M | 0.01% |
4,414,920
-778,520
| -15% | -$5.25M |
|
1030
Gentex
GNTX
$4.93B
| $28.2M | 0.01% |
1,715,152
+150
| +0% | +$2.62K |
|
|
SPLK
1031
DELISTED
Splunk Inc
SPLK
| $28.2M | 0.01% |
404,359
-644,188
| -61% | -$43.4M |
|
|
PSTB
1032
DELISTED
Park Sterling Corp.
PSTB
| $28M | 0.01% |
3,888,527
+130,700
| +3% | +$906K |
|
1033
Apogee Enterprises
APOG
$897M
| $28M | 0.01% |
531,780
-408,240
| -43% | -$22M |
|
1034
WSFS Financial
WSFS
$4.15B
| $28M | 0.01% |
1,022,650
+98,929
| +11% | +$2.51M |
|
1035
Gen Digital
GEN
$17.7B
| $27.8M | 0.01% |
1,193,738
+64,300
| +6% | +$1.57M |
|
1036
J.M. Smucker
SJM
$12.7B
| $27.7M | 0.01% |
255,909
-214,465
| -46% | -$24.8M |
|
1037
Lincoln National
LNC
$8.44B
| $27.7M | 0.01% |
467,975
+34,400
| +8% | +$2.01M |
|
1038
Visteon
VC
$2.84B
| $27.7M | 0.01% |
263,500
-56,460
| -18% | -$5.95M |
|
|
BHBK
1039
DELISTED
Blue Hills Bancorp, Inc.
BHBK
| $27.6M | 0.01% |
1,974,355
+254,291
| +15% | +$3.47M |
|
|
CUB
1040
DELISTED
Cubic Corporation
CUB
| $27.6M | 0.01% |
579,170
+92,780
| +19% | +$4.56M |
|
1041
Casey's General Stores
CASY
$31B
| $27.5M | 0.01% |
287,300
+99,800
| +53% | +$8.89M |
|
1042
Marriott Vacations Worldwide
VAC
$4.1B
| $27.5M | 0.01% |
299,668
+25,700
| +9% | +$2.19M |
|
1043
Patterson-UTI
PTEN
$4.2B
| $27.5M | 0.01% |
1,459,347
+1,026,390
| +237% | +$21.3M |
|
|
SQI
1044
DELISTED
SCIQUEST, INC. COMMON STOCK
SQI
| $27.4M | 0.01% |
1,850,911
+368,430
| +25% | +$5.76M |
|
1045
Helen of Troy
HELE
$696M
| $27.3M | 0.01% |
280,000
+18,000
| +7% | +$1.58M |
|
1046
Expedia Group
EXPE
$39.1B
| $27.2M | 0.01% |
248,320
+82,083
| +49% | +$8.49M |
|
1047
PUT
JPMorgan Chase
JPM
$965B
| $27.1M | 0.01% |
+400,000
| New | +$26.1M |
|
|
LVLT
1048
DELISTED
Level 3 Communications Inc
LVLT
| $27.1M | 0.01% |
514,552
-100,120
| -16% | -$5.49M |
|
1049
Immunic
IMUX
$217M
| $27M | 0.01% |
3,200
+2,124
| +197% | +$20.3M |
|
|
X
1050
DELISTED
US Steel
X
| $27M | 0.01% |
1,309,324
+146,633
| +13% | +$3.6M |
|
Similar funds
T. Rowe Price Associates's Q2 2015 Portfolio in Review
As of Q2 2015, T. Rowe Price Associates held 2,615 positions worth $486B, up 0.44% from $484B the previous quarter. Its ten largest holdings account for 14% of the portfolio.
T. Rowe Price Associates's Q2 2015 filing shows 76 new, 1,051 increased, 777 reduced and 79 closed positions. Its largest new stake was Allergan plc: 548,825 shares worth $570M. The largest sale was PHARMACYCLICS INC, an estimated $2.46B.
By sector, the portfolio is most concentrated in Healthcare at 23% of assets, up from 21% a quarter earlier, followed by Financials and Consumer Discretionary.
- T. Rowe Price Associates's largest Q2 2015 buy was Allergan plc: 548,825 shares worth $570M.
- T. Rowe Price Associates added most to Microsoft in Q2 2015, an estimated $3.76B increase.
- T. Rowe Price Associates's biggest Q2 2015 reduction was Wynn Resorts, cutting an estimated $1.11B.
- T. Rowe Price Associates fully exited PHARMACYCLICS INC in Q2 2015, selling an estimated $2.46B.
- T. Rowe Price Associates's ten largest holdings make up 14% of its $486B portfolio in Q2 2015.
- T. Rowe Price Associates opened 76 new positions and closed 79 in Q2 2015.
- T. Rowe Price Associates's portfolio value rose 0.44% quarter-over-quarter to $486B.
Based on T. Rowe Price Associates's 13F filing for Q2 2015, filed 14 Aug 2015.